# Multicenter, Randomized, Open-label, Parallel-group Study to Compare mLSG15 + KW-0761 to mLSG15

> **NCT01173887** · PHASE2 · COMPLETED · sponsor: **Kyowa Kirin Co., Ltd.** · enrollment: 44 (actual)

## Conditions studied

- Adult T-cell Leukemia-Lymphoma

## Interventions

- **DRUG:** VCAP/AMP/VECP(mLSG15)
- **BIOLOGICAL:** KW-0761

## Key facts

- **NCT ID:** NCT01173887
- **Lead sponsor:** Kyowa Kirin Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2017-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01173887

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01173887, "Multicenter, Randomized, Open-label, Parallel-group Study to Compare mLSG15 + KW-0761 to mLSG15". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01173887. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*